Healthcare ❯ Drug Development ❯ Clinical Trials ❯ Obesity Treatments

Phase 2 Trials

Novo Nordisk Raises Metsera Bid to $10 Billion, Outpacing Pfizer’s $8.1 Billion Counter

Delaware courts are fast-tracking Pfizer’s legal challenges ahead of a Nov. 13 shareholder vote.